Literature DB >> 21168220

SOCS3 suppresses the expression of IL-4 cytokine by inhibiting the phosphorylation of c-Jun through the ERK signaling pathway in rat mast cell line RBL-2H3.

Donghyun Kim1, Seon-Hee Kim, Sang-Heon Cho, Kichul Shin, Sunyoung Kim.   

Abstract

SOCS3 is well known to negatively regulate various cytokine-mediated signaling responses, but its direct role in the expression of specific cytokines has not been clearly elucidated. To understand the role of SOCS3 in the expression of IL-4, one of the key Th2 cytokines, RBL-2H3 cells (a rat mast cell line) were engineered to express SOCS3 constitutively at a high level or at a lower level using shRNA. In RBL-2H3 cells stably expressing SOCS3, the RNA and protein levels of IL-4 were significantly decreased, while it was opposite in RBL-2H3 cells containing shRNA for SOCS3. Overexpression of SOCS3 was found to reduce the level of calcium ionophore-induced phosphorylation of ERK1/2 and c-Jun transcription factor. Consistent with this data, knockdown of SOCS3 increased the level of phosphorylated ERK1 and ERK2. Taken together, SOCS3 appears to play an important role as a negative feedback inhibitor in the expression of IL-4 by inhibiting serine phosphorylation of c-Jun via the ERK signaling pathway. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168220     DOI: 10.1016/j.molimm.2010.11.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

2.  Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice.

Authors:  Kinuko Ohneda; Takashi Moriguchi; Shin'ya Ohmori; Yasushi Ishijima; Hironori Satoh; Sjaak Philipsen; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2014-03-10       Impact factor: 4.272

Review 3.  Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.

Authors:  Archana Shankar; Jaclyn W McAlees; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2022-08       Impact factor: 14.290

Review 4.  Group 2 ILCs: A way of enhancing immune protection against human helminths?

Authors:  N Nausch; F Mutapi
Journal:  Parasite Immunol       Date:  2017-07-12       Impact factor: 2.280

5.  Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease.

Authors:  Kelly Ceyzériat; Lucile Ben Haim; Audrey Denizot; Dylan Pommier; Marco Matos; Océane Guillemaud; Marie-Ange Palomares; Laurene Abjean; Fanny Petit; Pauline Gipchtein; Marie-Claude Gaillard; Martine Guillermier; Sueva Bernier; Mylène Gaudin; Gwenaëlle Aurégan; Charlène Joséphine; Nathalie Déchamps; Julien Veran; Valentin Langlais; Karine Cambon; Alexis P Bemelmans; Jan Baijer; Gilles Bonvento; Marc Dhenain; Jean-François Deleuze; Stéphane H R Oliet; Emmanuel Brouillet; Philippe Hantraye; Maria-Angeles Carrillo-de Sauvage; Robert Olaso; Aude Panatier; Carole Escartin
Journal:  Acta Neuropathol Commun       Date:  2018-10-16       Impact factor: 7.801

6.  LPS Guides Distinct Patterns of Training and Tolerance in Mast Cells.

Authors:  Marco De Zuani; Chiara Dal Secco; Silvia Tonon; Alessandra Arzese; Carlo E M Pucillo; Barbara Frossi
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.